Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.
Brache V, Croxatto H, Sitruk-Ware R, Maguire R, Montero JC, Kumar N, Salvatierra AM, Tejada AS, Cochón L, Forcelledo ML, Lahteenmaki P, Alvarez F, Faundes A. Brache V, et al. Among authors: faundes a. Contraception. 2007 Aug;76(2):111-6. doi: 10.1016/j.contraception.2007.04.005. Epub 2007 Jun 13. Contraception. 2007. PMID: 17656180 Free PMC article. Clinical Trial.
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Sitruk-Ware R, Brache V, Maguire R, Croxatto H, Kumar N, Kumar S, Montero JC, Salvatierra AM, Phillips D, Faundes A. Sitruk-Ware R, et al. Among authors: faundes a. Contraception. 2007 Jun;75(6):454-60. doi: 10.1016/j.contraception.2007.02.003. Epub 2007 Apr 18. Contraception. 2007. PMID: 17519152 Free PMC article. Clinical Trial.
Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.
Brache V, Croxatto H, Kumar N, Sitruk-Ware R, Cochón L, Schiappacasse V, Sivin I, Muñoz C, Maguire R, Faundes A. Brache V, et al. Among authors: faundes a. Contraception. 2009 Feb;79(2):150-4. doi: 10.1016/j.contraception.2008.08.010. Epub 2008 Nov 21. Contraception. 2009. PMID: 19135574 Free PMC article. Clinical Trial.
Contraceptive vaginal rings: a review.
Brache V, Faundes A. Brache V, et al. Among authors: faundes a. Contraception. 2010 Nov;82(5):418-27. doi: 10.1016/j.contraception.2010.04.012. Epub 2010 May 20. Contraception. 2010. PMID: 20933115 Review.
Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.
Brache V, Sitruk-Ware R, Williams A, Blithe D, Croxatto H, Kumar N, Kumar S, Tsong YY, Sivin I, Nath A, Sussman H, Cochon L, Miranda MJ, Reyes V, Faundes A, Mishell D Jr. Brache V, et al. Among authors: faundes a. Contraception. 2012 May;85(5):480-8. doi: 10.1016/j.contraception.2011.10.003. Epub 2011 Dec 15. Contraception. 2012. PMID: 22176795 Free PMC article. Clinical Trial.
Current status of contraceptive vaginal rings.
Brache V, Payán LJ, Faundes A. Brache V, et al. Among authors: faundes a. Contraception. 2013 Mar;87(3):264-72. doi: 10.1016/j.contraception.2012.08.037. Epub 2012 Oct 4. Contraception. 2013. PMID: 23040125 Review.
280 results